Adiposity markers and risk of coronary heart disease in patients with type 2 diabetes mellitus

Nutrition Journal

Table 2 Adiposity marker classification in patients with type 2 diabetes, stratified by CHD risk

	All patients	High risk (≥20%)	Low-moderate risk (<20%)	P ^a
n	420	99	321	-
Body mass index classification (WHO criteria) ^b	162 (38.6%)	30 (30.3%)	132 (41.1%)	0.030
Obesity (≥30.0 kg/m ² )
Waist circumference (IDF criteria) ^c:	361 (86.0%)	83 (83.8%)	278 (86.6%)	0.294
>80 cm for females and >94 cm for males
Waist-to-hip ratio (WHO criteria) ^b:	398 (94.8%)	97 (98.0%)	301 (93.8%)	0.080
>0.85 for females and >0.90 for males
Waist-to-height ratio ^d : >0.5	407 (96.9%)	96 (97.0%)	311 (96.9%)	0.630
Conicity index (mean): >1.35	211 (50.2%)	60 (60.6%)	151 (47.0%)	0.012
Body adiposity index (mean):	208 (49.5%)	47 (47.5%)	161 (50.2%)	0.363
>35 for females and >25 for males

CHD, coronary heart disease. The 10-year risk of fatal CHD was estimated according to UKPDS risk engine scores. Data are expressed as number of patients with the analyzed characteristic (%). ^aChi-square; abnormal levels for each adiposity marker defined as values higher than the sample mean (conicity and body adiposity indexes) or using well-known cutoffs established in the literature: ^bWHO criteria (1998); ^cInternational Diabetes Federation criteria for the European population (2005); ^dBrowning et al. (2010), Nutr Res Rev.

ISSN: 1475-2891